Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.
Bio-Techne
WHERE SCIENCE INTERSECTS INNOVATIONTM
![Flow Cytometry: Mouse TH1 Cell Flow Cytometry Kit [FMC010-NOV] - For Th1 activation, mouse splenocytes were cultured for 72 hours with 5 ng/mL of recombinant mouse IL-12, 10 ug/mL of anti-IL-4, 10 ug/mL of anti-CD3, and 10 ug/mL of anti-CD28 followed by 3 hours of re-stimulation with PMA-ionomycin and 3 uM of monensin. Cells were harvested and stained with the indicated antibodies following the procedure. Dot plots show the relative T-bet+, IFN-g+, and IL-12 RB+ populations from inactivated (A) and activated (B) CD4+-gated splenocytes. Quadrants were set based on isotype controls](http://images.novusbio.com/fullsize2/Mouse TH1 Cell Flow Cytometry Kit-Flow Cytometry-FMC010-NOV-img0002.jpg "Flow Cytometry: Mouse TH1 Cell Flow Cytometry Kit [FMC010-NOV] - For Th1 activation, mouse splenocytes were cultured for 72 hours with 5 ng/mL of recombinant mouse IL-12, 10 ug/mL of anti-IL-4, 10 ug/mL of anti-CD3, and 10 ug/mL of anti-CD28 followed by 3 hours of re-stimulation with PMA-ionomycin and 3 uM of monensin. Cells were harvested and stained with the indicated antibodies following the procedure. Dot plots show the relative T-bet+, IFN-g+, and IL-12 RB+ populations from inactivated (A) and activated (B) CD4+-gated splenocytes. Quadrants were set based on isotype controls")